use of an anti CD40L compound to treat a patient with an autoimmune disease or chronic immune system disorder

摘要

An anti-CD40L compound is used in the manufacture of a medicament for treating a patient with an autoimmune disease or chronic immune system disorder wherein: a therapeutic effective amount of the compound is administered to the patient for a first therapeutic period in doses separated by intervals of less than 3 weeks and then a therapeutic effective amount of the compound is administered to the patient for a second therapeutic period in doses separated by intervals of at least than 3 weeks. The anti-CD40L compound can be an antibody, complete Fab fragment, F(ab')2 compound, VH region, FV region or a single chain antibody.